Ruby Mills schedules 110th AGM for September 24, 2026

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • 110th AGM scheduled for September 24, 2026, at 4:30 pm
  • Meeting conducted via VC/OAVM per MCA circulars
  • FY26 Annual Report sent electronically to registered holders
  • E-voting facility provided by NSDL for shareholder resolutions
powered bylight_fuzz_icon
49377634

*this image is generated using AI for illustrative purposes only.

Ruby Mills has scheduled its 110th Annual General Meeting (AGM) for September 24, 2026. The meeting will be conducted through Video Conferencing or Other Audio Visual Means (VC/OAVM) in compliance with Ministry of Corporate Affairs circulars.

The company announced the date in a disclosure filed on August 27, 2026. The AGM is set to begin at 4:30 pm at the deemed venue of the registered office in Mumbai.

Meeting Details and Logistics

Shareholders can participate remotely without physical presence. The company will count attendees joining via VC/OAVM toward the quorum requirement under Section 103 of the Companies Act, 2013.

Detail Information
Meeting Date September 24, 2026
Time 4:30 pm
Mode VC/OAVM
Deemed Venue Registered Office, Mumbai

Shareholder Communications

The Notice of the AGM along with the Annual Report for FY26 will be sent electronically to shareholders with registered email addresses. Those without registered emails will receive a letter containing a weblink to access these documents.

The documents are also available on the company website, NSE, BSE, and NSDL e-voting platforms. Ruby Mills has engaged National Securities Depository Limited to facilitate e-voting for resolutions proposed at the meeting.

Compliance Updates

In line with SEBI Master Circular dated February 6, 2026, dividends will be paid only in electronic form to KYC-compliant folios. Physical shareholders are requested to update PAN, bank details, and nomination information with the Registrar and Transfer Agent, Big Share Services Private Limited.

Historical Stock Returns for Ruby Mills

1 Day5 Days1 Month6 Months1 Year5 Years
-0.79%-4.84%-4.16%+106.51%+72.74%+189.34%

What specific strategic initiatives or financial performance metrics will likely dominate the discussion at Ruby Mills' 110th AGM?

How might the mandatory shift to electronic dividend payments impact shareholder participation rates among non-KYC compliant investors?

Are there any proposed changes to the board composition or executive compensation that shareholders should anticipate in the upcoming resolutions?

Ruby Mills sells The Ruby 33rd floor to Torrent Pharma for ₹124.08 crore

scanx
Reviewed by
Ritika DScanX News Team
Key Highlights
  • Ruby Mills sold 33rd-floor commercial space at The Ruby to Torrent Pharmaceuticals
  • Transaction value stands at ₹124.08 crore including parking spaces
  • Deal completed on August 19, 2026; disclosed on August 20, 2026
  • Buyer is unrelated to Ruby Mills promoters; not a related-party transaction
powered bylight_fuzz_icon
48769800

*this image is generated using AI for illustrative purposes only.

The Ruby Mills has sold commercial premises on the 33rd floor of its property 'The Ruby' to Torrent Pharmaceuticals Limited for ₹124.08 crore.

Transaction details

The sale, which includes associated car parking spaces, was completed on August 19, 2026. The transaction was disclosed to stock exchanges on August 20, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Parameter Details
Property The Ruby
Floor 33rd floor
Space type Commercial premises with parking
Buyer Torrent Pharmaceuticals Limited
Transaction value ₹124.08 crore
Completion date August 19, 2026

The buyer, Torrent Pharmaceuticals, is not part of the promoter group or group companies of The Ruby Mills Limited. Consequently, the transaction does not fall under related-party transactions. The sale is outside any Scheme of Arrangement and is independent of any restructuring.

Historical Stock Returns for Ruby Mills

1 Day5 Days1 Month6 Months1 Year5 Years
-0.79%-4.84%-4.16%+106.51%+72.74%+189.34%

How will the ₹124.08 crore inflow from this asset sale impact The Ruby Mills' debt-to-equity ratio and overall liquidity position?

What strategic initiatives or capital allocation plans has The Ruby Mills outlined for the proceeds generated from this non-core asset divestment?

Does Torrent Pharmaceuticals' acquisition of premium office space in 'The Ruby' signal an expansion in their corporate footprint or a shift in their real estate investment strategy?

More News on Ruby Mills

1 Year Returns:+72.74%